This site is intended for healthcare professionals

NICE reverses decision and now recommends use of Tecentriq plus Abraxane in metastatic triple negative breast cancer.- Roche

Read time: 1 mins
Last updated:26th May 2020
Published:23th May 2020
Condition: Breast Cancer Triple Neg
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest